Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Portfolio > Mutual Funds > Target Date Funds

MFS Cuts Fees on Target Date Funds

X
Your article was successfully shared with the contacts you provided.

MFS has introduced enhancements to its target date funds that will lower fees significantly.

Across the MFS Lifetime Funds, which is MFS’ suite of target date products, fees are being lowered by 15 to 22 basis points depending on the fund.

“A couple of things that we were looking at as related to client demand and trends in the industry was in particular the asset allocation mix, how we continue to build out further diversification, and secondarily looking at fee structures and the attractiveness of the fees,” Ryan Mullen, head of defined contribution investments at MFS, told ThinkAdvisor.

MFS launched its Lifetime Funds suite in 2005, and the last time the firm introduced enhancements to the suite that lowered fees was 2012.

MFS was able to lower fees this year by making two specific changes.

First, MFS looked at its overlying asset allocation mix and decided to add its seven MFS Blended Research Funds to the underlying target date lineup. These funds have been available for more than 15 years on the institutional side and as stand-alone mutual funds.

“Previously we had not had them in the target date suite and we felt like adding those in … would diversify the underlying investments to provide additional layers of alpha while still staying completely active in terms of our approach,” Mullen told ThinkAdvisor.

The addition of the blended research funds provides further diversification of alpha profiles within the equity allocation, as well as reduces overall expenses of the MFS Lifetime Funds by 3 to 8 basis points across all share classes.

“That was the first component: How do we continue to enhance the asset allocation and the active management approach but also addressing a trend in the industry of making sure fees are reasonable and attractive?” Mullen explained.

The second component that allowed MFS to lower fees on its suite of target-date funds was the introduction of the R6 share class, basically a “zero revenue share class.”

“What we have seen is a dramatic increase in the zero revenue share class and the interest from clients,” Mullen said.

“Our Lifetime Funds now offer a zero revenue share class, which there’s no subaccounting [and] no revenue sharing in that particular share class,” Mullen explained. “So it’s really isolating the asset management fee, and you’re able to offer a really competitive share class structure.”

This is helping MFS to reduce fees across the Lifetime suite by another 10 to 14 basis points depending on the fund.

Fees for the funds now range from 44 to 52 basis points, “which will put us significantly below median and very attractive while still maintaining a full active risk managed approach,” Mullen said.

While Mullen is a “firm believer in fees being reasonable,” he does think there’s been a “myopic focus” on fees lately. This may be in part due to the increased focus on being a fiduciary following the passing of the Department of Labor’s fiduciary rule, which has put a continued focus on making sure fees are reasonable.

But Mullen warns that “by focusing solely on fees you’re missing the bigger picture.”

“There’s no fiduciary hall pass for going passive,” he told ThinkAdvisor. “By focusing solely on fees, you’re not paying enough attention to things that matter. I look at risk management as one area that if you’re fully going passive and only focused on lowering fees, you’re not getting exposure to risk management exposures that can help protect investors in periods of volatility or events like the global financial crisis.”

— Related on ThinkAdvisor:


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.